Results of Placement
Filed with ASX · · 4 pages · English
Summary by 6ix AI
The placement raised funds from professional and sophisticated investors to support regulatory studies for Flavocide and increase production of Qcide. The company plans to offer eligible shareholders the opportunity to acquire additional shares under the share purchase plan without incurring transaction costs.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Bio-Gene Technology Ltd. on 6ix
In the deck
Story so far
Earlier from Bio-Gene Technology
- Sumitomo & Nakashima to launch Qcide products in Japan
- Regulatory Development of Flavocide
- Appendix 4D and Half-Year Accounts 31 December 2025
- Quarterly Activities/Appendix 4C Cash Flow Report
- U.S. Department of Defense Grant Programs Advance
Later from Bio-Gene Technology
All Bio-Gene Technology news releasesFollow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology